Biomarkers Say COVID-19 Brain Damage Is Like Alzheimer’s, But Faster

By | January 18th, 2022

COVID-19 and Alzheimer's share the same brain damage biomarkers. Blood samples reveal they accumulate at higher levels over a shorter period of time in COVID patients.

If you find our articles and interviews helpful, please consider becoming a supporting member of our community. Frustrated by the lack of an editorially independent source of information on brain health and Alzheimer’s disease, we decided to create Being Patient. We are a team of dedicated journalists covering the latest research on Alzheimer’s, bringing you access to the experts and elevating the patient perspective on what it’s like to live with dementia.

Please help support our mission.

Leave a Reply

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.